Mimedx (MDXG) Change in Receivables (2011 - 2026)

Mimedx has disclosed Change in Receivables across 15 years of filings, most recently posting $545000.0 for Q2 2026.

• In Q2 2026, Change in Receivables fell 92.52% year-over-year to $545000.0; the TTM figure through Jun 2026 stood at -$15.8 million (down 189.06% YoY), while the FY2025 annual figure was $26.4 million, up 934.25% from the prior year.
• Change in Receivables came in at $545000.0 for Q2 2026 at Mimedx, up from -$28.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $11.0 million in Q3 2025 to a low of -$28.2 million in Q1 2026.
• Average Change in Receivables over 5 years is $1.1 million, with a median of $2.3 million recorded in 2022.
• Year-over-year, Change in Receivables sank 89200.0% in 2022 and surged 1055.72% in 2025.
• Over 5 years, Change in Receivables stood at $2.6 million in 2022, then surged by 111.13% to $5.6 million in 2023, then sank by 59.61% to $2.3 million in 2024, then tumbled by 60.63% to $887000.0 in 2025, then tumbled by 38.56% to $545000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $545000.0 in Q2 2026, -$28.2 million in Q1 2026, and $887000.0 in Q4 2025.